Sign In
Buy HOLX
$76.01
+0 (+0%)
At Close: Jun 03, 2026
BALA CYNWYD, Pa. , Dec. 23, 2025 (GLOBE NEWSWIRE) -- Brodsky and Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
10:00am, Tuesday, 23'rd Dec 2025
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
HOLX vs. LH: Which MedTech Stock Is the Stronger Investment Now?
09:01am, Monday, 22'nd Dec 2025
Labcorp's strategic partnerships, specialty test growth and more attractive valuation tilt the balance as it emerges stronger than Hologic right now.
HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases
01:06pm, Wednesday, 17'th Dec 2025
Hologic shares dip as the company unveils new study data showing its Genius AI mammography flags 32% of previously missed breast cancer cases.
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term
10:51am, Wednesday, 17'th Dec 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Hologic's Genius AI Detection Shows Value by Spotting Missed Cancers
09:31am, Wednesday, 17'th Dec 2025
HOLX's Genius AI Detection flags missed breast cancers, showing promise in improving mammography accuracy and radiologist efficiency.
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #AI--Hologic's AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exam
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
10:00am, Friday, 12'th Dec 2025
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
What Is Driving Hologic's Strength in the US Diagnostics Market?
08:36am, Friday, 12'th Dec 2025
HOLX's Diagnostics gains accelerate as U.S. molecular testing drives growth and new Panther Fusion and Genius platform approvals widen its runway.
Halper Sadeh LLC Encourages DHIL, SNCR, FRGE, HOLX Shareholders to Contact the Firm to Discuss Their Rights
08:54pm, Thursday, 11'th Dec 2025
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
First Trust Advisors LP Sells 2,413,872 Shares of Hologic, Inc. $HOLX
04:58am, Thursday, 11'th Dec 2025
First Trust Advisors LP cut its holdings in shares of Hologic, Inc. (NASDAQ: HOLX) by 83.4% during the undefined quarter, according to the company in its most recent disclosure with the Securities and
Blue Door Asset Management LLC Takes Position in Hologic, Inc. $HOLX
04:20am, Thursday, 11'th Dec 2025
Blue Door Asset Management LLC acquired a new position in shares of Hologic, Inc. (NASDAQ: HOLX) during the second quarter, according to the company in its most recent Form 13F filing with the Securit
HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026?
10:21am, Monday, 08'th Dec 2025
Hologic shares rise 16% in six months, with divisional strength clinical data and a go-private deal shaping the short-term outlook.
Edgestream Partners L.P. Has $1.92 Million Stock Holdings in Hologic, Inc. $HOLX
04:10am, Saturday, 06'th Dec 2025
Edgestream Partners L.P. lifted its holdings in shares of Hologic, Inc. (NASDAQ: HOLX) by 75.5% during the undefined quarter, according to the company in its most recent 13F filing with the Securities
Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions
11:26am, Thursday, 04'th Dec 2025
HOLX's BCI test gains traction as new SABCS studies are set to highlight its growing role in guiding extended endocrine therapy decisions.
